Immucell (ICCC) - Potential Treatment for Cryptosporidium Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucell (ICCC) - Potential Treatment for Cryptosporidium

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jonathan Rothschild who wrote (17)	6/8/1997 8:34:00 PM
From: Jonathan Rothschild	of 46

I just attended Friday's annual shareholders meeting and found it very positive. There are some heavyweights on the board including the former governor of Maine and others with excellent contacts within the biotech industry. The executive officers are not flashy, salesmen types, which may account for part of their weakness in waking up the investment community. This is the year which will turn the company around as 4 major events are happening. Lactoferrin production will start this summer; it's a joint venture with the largest diary co-op in New England. They already have orders in Asia. Environmental crypto diagnostic will go on sale in Europe next month and U.S. will follow soon. We will have results from phase 2 clinical trials from their two lead products, Diffgam and Travelgam, this year. If only one is positive, this could be a second tier biotech company, leaping from a market cap of 6 MM to 60 MM. Company knows how to manage cash and uses partners to fund most of their trial expenses. They manufacture in house. Employee morale is great; they stay late and the floors are clean. More to follow if anyone's interested.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next